Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2(†)

Bilateral vestibular schwannomas are the hallmark of neurofibromatosis type 2 (NF2), and these tumors impair hearing and frequently lead to deafness. Neurosurgical intervention, the only established treatment, often damages the vestibular nerve. We report 2 cases in which treatment with bevacizumab...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Mautner, Victor-Felix, Nguyen, Rosa, Kutta, Hannes, Fuensterer, Carsten, Bokemeyer, Carsten, Hagel, Christian, Friedrich, Reinhard E., Panse, Jens
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2010
Gaiak:
Rapid Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2940556/
https://ncbi.nlm.nih.gov/pubmed/20150363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nop010
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak